Dietary Resistant Starch Protects Against Diabetic Nephropathy by Inhibition of Complement


Date
Location
Sydney, Australia

Abstract:

Aim To investigate immune mechanisms by which resistant starch (RS) supplementation may be protective against diabetic nephropathy.

Background Activation of complement occurs in diabetic nephropathy. C5a is a downstream complement component that activates the innate immune system contributing to inflammation. Dietary RS may be nephro-protective, however the effects of dietary RS on complement activation and the innate immune system have not been explored.

Methods Six week old non-diabetic mice (db/h), diabetic mice (db/db) and db/db mice on a regular chow diet supplemented with 25% RS (dbdb+RS) were maintained for ten weeks. 24-hour urine was collected for albumin and C5a measurement by ELISA. Kidneys were digested and enriched for leukocytes using Percoll gradient. Cells were stained with BV786-CD45, AF700-CD11b, PE-Cy7-CD11c, BV711-Siglec F, BV605-Ly6C, PE-CD86, FITC-C5aR antibodies and flow cytometry was performed.

Results Diabetes was associated with an increase in albuminuria (28.0±6.5 vs 411.3±275.8µg/24h, P<0.001, dbh vs dbdb), which was reduced in diabetic mice receiving RS supplementation (411.3±275.8 vs 125.6±37.3µg/24h, P<0.01, dbdb vs dbdb+RS). Urinary C5a excretion was increased by diabetes (92.6±17.6 vs 1324.0±429.7pg/24h, P<0.001, dbh vs dbdb) and decreased by RS (1324.0±429.7 vs 577.7±123.1pg/24h, P<0.05, dbdb vs dbdb+RS). In diabetes there was an increase in CD86 MFI (a marker of activation) on infiltrating macrophages (CD45+ CD11b+ CD11c- Siglec F- Ly6C hi), which was attenuated with RS (3.7±1.8 vs 1.5±1.0 fold change to dbh, P<0.05, dbdb vs dbdb+RS). Furthermore, infiltrating macrophages were more likely to be positive for C5aR with diabetes (4.8±3.9 vs 54.0±27.8%, P<0.001, dbh vs dbdb), which RS supplementation reduced (54.0±27.8 vs 11.7±4.2%, P<0.01, dbdb vs dbdb+RS).

Conclusions These studies support the notion that dietary RS is protective against renal disease via inhibition of complement.

Avatar
Matthew Snelson
Research Fellow, Department of Diabetes

My research interests include diet-microbiota interactions, diabetic kidney disease and prebiotics